Researchers assessed the risk for serious infection during pregnancy and postpartum based on TNF inhibitor exposure among women with chronic inflammatory disease.

Patients with SSc were linked to an increased risk for hematological malignancies, specifically B-cell malignancies.

Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in systemic lupus erythematosus.

Circadian rhythms that are weaker and more fragmented are associated with an increased risk for dementia, according to a recent study.

About one-quarter of women report leisure-time activity meeting recommendations for both aerobic and muscle-strengthening physical activity.

Financial strain and food insecurity are drivers of accelerated biological heart aging, according to a recent study.

Topline data were announced from the phase 3 INDIGO trial evaluating obexelimab in adults with immunoglobulin G4-related disease.

Following the January 2025 wildfires affecting Los Angeles, there was an increase in emergency encounters for certain diagnoses.

Shorter leukocyte telomere length may serve as a useful biomarker for identifying patients at increased risk of developing pSS.

Researchers evaluated whether pregnancy complications, early childhood characteristics, and tobacco-related exposures were associated with SARDs.

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk reduction.

Adults who experienced a fall-related hip fracture and lived in a more deprived neighborhood spent fewer days at home following the fracture.